VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA ...

Harmer's nose he saw such extensive damage to the lining that he asked the father-of-one if he had been a habitual cocaine ...

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...